Search

everythinglearnresearchcommunity

for

Search:↓

Certain natural and synthetic compounds may help treat inflammatory skin diseases by targeting a specific signaling pathway.

Thyroid and skin autoimmune diseases share genetic and immune links, affecting both tissues.

Antioxidant nanoparticles show promise for treating inflammatory diseases but need more research for safe and effective use.

Androgenetic alopecia involves immune cell disruptions, especially increased CD4+ T cells around hair follicles.

The research suggests immune system changes and specific gene expression may contribute to male hair loss, proposing potential new treatments.

CCCA involves immune response and metabolism issues, suggesting new treatment options.

Special immune cells called Treg cells are important for maintaining and regenerating hair by activating a specific growth signal in hair stem cells.

SOX10 in hair follicles is linked to inflammation in alopecia areata.

Lower CD200R1 on certain immune cells is linked to more severe rheumatoid arthritis and immune imbalance.

Extracellular vesicles could offer precise treatments for psychiatric conditions by targeting brain networks.

The paper concludes that the patchiness of alopecia areata is likely due to when the immune attack happens in the hair growth cycle.

Alopecia areata is an autoimmune disorder causing hair loss, linked to specific hair follicle antigens and genetic factors.

New treatments for hair loss are showing promise due to better understanding of genetics and the immune system.

COVID-19 may affect male fertility and women might have better outcomes due to hormonal and immune differences.

Alopecia areata patients have higher IgE and IL-13 levels, suggesting immune involvement.

Certain immune molecules and stress affect hair loss, and while genes play a role, more research is needed to fully understand and treat it.

Controlled delivery of specific RNA and IL-4 restored hair growth in mice with autoimmune alopecia.

Alopecia areata involves persistent gene abnormalities and immune activity, even in regrown hair, suggesting a risk of relapse.

BST2 is highly expressed in certain immune cells in alopecia areata, suggesting a role in the disease.

Lichen planopilaris causes permanent hair loss and scarring due to damage to hair follicles and can be mistaken for other hair loss conditions.

Higher levels of PD-L1 are linked to more severe hair loss in people with Alopecia Areata.

Alopecia Areata affects 2% globally, with treatments like essential oils, garlic, and JAK inhibitors showing promise, but more research is needed.

The scalp's microorganisms significantly affect hair health and disease.

New treatments focusing on immune pathways show promise for stubborn hair loss.

Hair follicle-derived IL-7 and IL-15 are crucial for maintaining skin-resident memory T cells and could be targeted for treating skin diseases and lymphoma.

Stem Cell Educator therapy helps regrow hair and improve life quality in alopecia areata patients.

Vitamin A affects hair loss and immune response in alopecia areata.

OX40-targeted therapies may help treat skin diseases by reducing inflammation and balancing immune responses.

Oral lichen planus is a chronic disease causing mouth discomfort and sometimes needs immunosuppressive treatment.

Using an anti-ICAM-1 antibody with rapamycin improves hair transplant survival in monkeys.